Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union

Affiliations

• ¹ Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. [email protected].
• ² Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. [email protected].
• ³ Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. [email protected].
• ⁴ Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. [email protected].
• ⁵ Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. [email protected].
• ⁶ Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, Bonn, 53175, Germany. [email protected].
• ⁷ Läkemedelsverket, Dag Hammarskjölds vägen 42, Uppsala, 75103, Sweden. [email protected].
• ⁸ Research Institute for Medicines (iMED.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisboa, 1649-003, Portugal. [email protected].